Disease areas:
  • gut health
Last updated:
Author(s):
Uri Kartoun, Akira Koseki, Akihiro Kosugi, Kingsley Njoku, Tesfaye Yadete, Eileen Koski, Joao Bettencourt-Silva, Natasha Mulligan, Jianying Hu, Julia Liu, Thaddeus Stappenbeck, Vibha Anand
Publish date:
25 November 2024
Journal:
Scientific Reports
PubMed ID:
39587092

Abstract

Although corticosteroids are an important treatment for inflammatory bowel disease (IBD) patients, many subjects develop dependence, leading to serious long-term side effects. We applied causal inference analyses to investigate the length of steroid use on reoperations in IBD patients. We identified subjects in the UK Biobank general practice dataset with at least one major GI surgery and followed them for at least 5 years to evaluate subsequent operations. We defined steroid dependence as at least 12 weeks of use (vs. acute steroid use) prior to baseline surgery. Of the 363 subjects included in our analyses, 163 (45%) were prescribed steroids on or before baseline surgery, and of these (N = 125 of 163, 77%) were dependent. Additional analyses for time-dependent data on prescriptions found a link between prescription length and reoperation. Among UC subjects with acute use, the odds of reoperation were significantly lower (OR: 0.32, 95% CI: 0.0-0.73). Steroid dependence resulted in a delay of reoperation (median 1.2 vs. 2.3 years, P = 0.01). Our findings indicate that long-term steroid use tends to increase the need for reoperation, whereas short-term use may reduce it.

Related projects

With the increasing volume and variety of health data that is being collected, there is an important need for tools to help make sense of…

Institution:
IBM Research, United States of America

All projects